8
Views
35
CrossRef citations to date
0
Altmetric
Cell Growth and Development

Integration of Growth Factor, Extracellular Matrix, and Retinoid Signals during Bronchial Epithelial Cell Differentiation

&
Pages 6666-6678 | Received 23 Mar 1998, Accepted 21 Jul 1998, Published online: 28 Mar 2023
 

ABSTRACT

Epithelial cell differentiation is regulated by specific combinations of growth factors, hormones, and extracellular matrix (ECM). How these divergent signals are integrated is largely unknown. We used primary cultures of normal human bronchial epithelial cells (NHBEs) to investigate mechanisms of signal integration. In defined, serum-free media, NHBEs undergo mucosecretory differentiation only when grown in the presence of retinoids and on the appropriate substratum (collagen gels). We identified the retinoic acid receptor β (RARβ) gene as an early marker of NHBE differentiation. In contrast to immortalized cell lines, in NHBEs strong retinoid-induced RARβ transcription occurs only when cells are grown on collagen gels, and it requires new protein synthesis and a cis-acting element that maps outside the known RARβ promoter elements. NHBEs grown on collagen gels exhibit reduced epidermal growth factor (EGF)-induced Raf, MEK, and mitogen-activated protein kinase (MAPK) activity. This correlates with a specific inability to achieve high levels of p66SHC tyrosyl phosphorylation and association of p66SHC with GRB2, despite high levels of EGF receptor (EGFR) autophosphorylation. Notably, inhibition of EGFR or MEK/MAPK activation replaces the ECM requirement for RARβ induction. Our results strongly suggest that a key mechanism by which specific ECMs facilitate retinoid-induced mucosecretory differentiation of NHBEs is by restricting the level of EGFR-dependent MEK/MAPK activation evoked by autocrine and/or paracrine EGFR ligands.

ACKNOWLEDGMENTS

We thank M. Klaus for Ro 19-0645, R. Wu for antimucin antibody 17B1, W. Pear for BING cells, W. Chin for αRXR antibodies, R. L. Erikson, B. Brott, A. Alessandrini, and Y. Gotoh for αMEK antibodies and GST-Erk1(K63M) fusion protein, K. L. Guan for GST-MEK(K97A) fusion protein, J. Blenis for αErk1/2 antiserum, S. Soltoff for AG1478, and J. Timms for assistance with the final stages of this work. We also thank Y. Gotoh, L. Klaman, C. Carpenter, and K. Carraway for helpful discussions.

This work was supported by grant CA-49152 from the National Institutes of Health to B.G.N.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.